Vimarsana
Biggest News Aggregation in the World

Johnj Sninsky News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Johnj Sninsky. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Johnj Sninsky Today - Breaking & Trending Today

Molecular Stethoscope's cf-mRNA liquid biopsy machine learning platform used in a mouse model of inflammation and pharmacologic intervention study published in eBiomedicine - Vimarsana News

Molecular Stethoscope's cf-mRNA liquid biopsy machine learning platform used in a mouse model of inflammation and pharmacologic intervention study published in eBiomedicine

/PRNewswire/ -- Molecular Stethoscope, a leading precision medicine company pioneering the next-generation cell-free mRNA (cf-mRNA) liquid biopsy, announced...

Molecular Stethoscope, Inc. Announces Presentation at 16th Annual Sequencing to Function: Analysis and Applications for the Future Meeting - Vimarsana News

Molecular Stethoscope, Inc. Announces Presentation at 16th Annual Sequencing to Function: Analysis and Applications for the Future Meeting

/PRNewswire/ -- Molecular Stethoscope, Inc., a Precision Medicine biotechnology company, announces a presentation at the 2021 16th annual Sequencing to...

Molecular Stethoscope Announces Completion and Publication of its Alzheimer's Disease Study in Science Advances - Vimarsana News

Molecular Stethoscope Announces Completion and Publication of its Alzheimer's Disease Study in Science Advances

Molecular Stethoscope Announces Completion and Publication of its Alzheimer's Disease Study in Science Advances Study results highlight the Company's Next-Generation cf-mRNA Liquid Biopsy-Artificial Intelligence Technology Platform for characterization of Alzheimer's Disease PALO ALTO, Calif., Dec. 14, 2020 /PRNewswire/ -- Molecular Stethoscope, Inc., a precision medicine biotechnology company, announces publication of a human proof-of-concept study for Alzheimer's Disease using its proprietary cell-free messenger RNA (cf-mRNA)-Artificial Intelligence Technology Platform. The study appeared ...